131 related articles for article (PubMed ID: 38330618)
1. Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions.
Brogård MB; Nielsen PS; Christensen KB; Georgsen JB; Wandler A; Lade-Keller J; Steiniche T
Pathol Res Pract; 2024 Mar; 255():155177. PubMed ID: 38330618
[TBL] [Abstract][Full Text] [Related]
2. Automated quantification of MART1-verified Ki-67 indices: useful diagnostic aid in melanocytic lesions.
Nielsen PS; Spaun E; Riber-Hansen R; Steiniche T
Hum Pathol; 2014 Jun; 45(6):1153-61. PubMed ID: 24704158
[TBL] [Abstract][Full Text] [Related]
3. Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions.
Nielsen PS; Riber-Hansen R; Raundahl J; Steiniche T
Arch Pathol Lab Med; 2012 Jun; 136(6):627-34. PubMed ID: 22646269
[TBL] [Abstract][Full Text] [Related]
4. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
[TBL] [Abstract][Full Text] [Related]
5. Digital Quantification of Melanocytic Density in Resection Margins of Lentigo Maligna Using SOX10 Versus Hematoxylin-Eosin Staining.
Siarov J; Neittaanmäki N; Mölne J; Gillstedt M; Paoli J
Am J Dermatopathol; 2021 Apr; 43(4):273-277. PubMed ID: 32675472
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
[TBL] [Abstract][Full Text] [Related]
7. Observational Study Examining the Diagnostic Practice of Ki67 Staining for Melanocytic Lesions.
Vyas NS; Charifa A; Desman GT; Goldberg M; Singh R; Phelps RG; McNiff JM
Am J Dermatopathol; 2019 Jul; 41(7):488-491. PubMed ID: 31233404
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
Nielsen PS; Riber-Hansen R; Steiniche T
Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
[TBL] [Abstract][Full Text] [Related]
9. Automated quantification of Ki67/MART1 stains may prevent false-negative melanoma diagnoses.
Wandler A; Spaun E; Steiniche T; Nielsen PS
J Cutan Pathol; 2016 Nov; 43(11):956-962. PubMed ID: 27461337
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67.
Milman T; Zhang Q; Ang S; Elder D; Ida CM; Salomao DR; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
Hum Pathol; 2020 Sep; 103():107-119. PubMed ID: 32707054
[TBL] [Abstract][Full Text] [Related]
11. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY
Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16.
Milman T; Zhang Q; Ang S; Elder D; Lally SE; Shields JA; Hamershock RA; Sioufi K; Shields CL; Eagle RC
Am J Ophthalmol; 2021 Feb; 222():148-156. PubMed ID: 33002486
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
14. SOX10 commonly stains scar in Mohs sections.
Donaldson MR; Weber LA
Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155034
[TBL] [Abstract][Full Text] [Related]
15. Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Rothberg BE; Moeder CB; Kluger H; Halaban R; Elder DE; Murphy GF; Lazar A; Prieto V; Duncan LM; Rimm DL
Mod Pathol; 2008 Sep; 21(9):1121-9. PubMed ID: 18552823
[TBL] [Abstract][Full Text] [Related]
16. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
17. Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Schmidt H; Steiniche T
Diagn Pathol; 2016 Apr; 11():35. PubMed ID: 27062658
[TBL] [Abstract][Full Text] [Related]
18. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
[TBL] [Abstract][Full Text] [Related]
20. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]